Trimble R B, Tarentino A L
Division of Clinical Sciences, New York State Department of Health, Albany 12201-0509.
J Biol Chem. 1991 Jan 25;266(3):1646-51.
Flavobacterium meningosepticum endo-beta-acetyl-glucosaminidase F preparations have been resolved by hydrophobic interaction chromatography on TSK-butyl resin into at least three activities designated endo F1, endo F2 and endo F3 each with a unique substrate specificity. The 32-kDa endo F1 protein is the principle component representing in excess of 95% of most earlier and currently available commercial endoglycosidase preparations, the remainder being a mixture of five proteins from 32 to 43 kDa. Substrate specificity studies reveal endo F1 and endo H from Streptomyces plicatus to have nearly identical capacities to hydrolyze high-mannose oligosaccharides with a minimum Man1 alpha 3Man1 alpha 6Man1 beta 4GlcNAc1 beta 4GlcNAc structure. Although endo H will hydrolyze fucose-containing hybrid oligosaccharides at rates approaching comparable high-mannose forms, core-linked fucose reduces the hydrolysis rate of endo F1 by over 50-fold relative to high-mannose structures. Neither homogeneous endo F1 nor endo H hydrolyze complex multi-antennary glycans. The biantennary cleaving activity previously reported for endo F preparations (Tarentino, A. L., Gómez, C. M., and Plummer, T. H., Jr. (1985) Biochemistry 24, 4665-4671) is a characteristic of the contaminating endo F2 activity.
脑膜败血金黄杆菌内切β-乙酰氨基葡糖苷酶F制剂已通过在TSK-丁基树脂上的疏水相互作用色谱法分离为至少三种活性,分别命名为内切F1、内切F2和内切F3,每种活性都具有独特的底物特异性。32 kDa的内切F1蛋白是主要成分,在大多数早期和目前可用的商业内切糖苷酶制剂中占比超过95%,其余部分是32至43 kDa的五种蛋白质的混合物。底物特异性研究表明,来自褶皱链霉菌的内切F1和内切H具有几乎相同的水解高甘露糖寡糖的能力,其最小结构为Man1α3Man1α6Man1β4GlcNAc1β4GlcNAc。尽管内切H将以接近可比的高甘露糖形式的速率水解含岩藻糖的杂合寡糖,但核心连接的岩藻糖相对于高甘露糖结构使内切F1的水解速率降低了50倍以上。均一的内切F1和内切H都不水解复杂的多天线聚糖。先前报道的内切F制剂的双天线切割活性(Tarentino,A. L.,Gómez,C. M.,和Plummer,T. H.,Jr.(1985年)生物化学24,4665-4671)是污染的内切F2活性所特有的。